← Leaderboards
Richard Joseph Johnson
Colorado Research Partners, Llc
$6,102,731
Attributed
$6,102,731
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2019–23$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$6,102,731 · 1
By mechanism
U01$6,102,731 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Combat”
- John Damon Chodera · Sloan-Kettering Inst Can Research$33,555,942
- Greg Witham · Anp Technologies, Inc.$19,727,817
- Bruce Blough · Research Triangle Institute$19,637,160
- Ryan Cirz · Revagenix, Inc.$17,912,826
- Robert Frenck · Cincinnati Childrens Hosp Med Ctr$14,263,734
- Jurgen Bernd Bulitta · State University Of New York At Buffalo$12,646,803
Research focus
CombatCommercializationColoradoAlcohol Abuse TherapyAdultAbsorptionAddictionCohortAlcohol Use DisorderAmes AssayAnimalsAlcohol ConsumptionAutomobile DrivingAlcohol DependenceAlcoholismAffectAlcoholsBiological AvailabilityBloodCanis FamiliarisCessation Of LifeClinicClinical TrialsContracts
Grant awards (5)
Fructokinase Inhibitors for the Treatment of Alcohol Use Disorder$1,151,963
U01 · FY2023 · AA · contact PI
Fructokinase Inhibitors for the Treatment of Alcohol Use Disorder$1,163,856
U01 · FY2022 · AA · contact PI
Fructokinase Inhibitors for the Treatment of Alcohol Use Disorder$1,233,319
U01 · FY2021 · AA · contact PI
Fructokinase Inhibitors for the Treatment of Alcohol Use Disorder$1,259,901
U01 · FY2020 · AA · contact PI
Fructokinase Inhibitors for the Treatment of Alcohol Use Disorder$1,293,692
U01 · FY2019 · AA · contact PI